Heroin and cocaine vaccines successful in preclinical studies

Science Spotlight

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current news releases on nida.nih.gov.

Two recent preclinical studies have reported successful tests for vaccines to help overcome heroin or cocaine addiction.

For a copy of the study abstract on the heroin vaccine (published online May 6), go to: www.pnas.org/content/early/2013/05/02/
1219159110.abstract
.

For a copy of the press release from The Scripps Research Institute, go to: www.scripps.edu/news/press/2013/20130506heroin.html.

For a copy of the study abstract on the cocaine vaccine (published online May 10), go to:www.nature.com/npp/journal/vaop/naam/abs/npp2013114a.html. For a copy of the press release from Weill Cornell Medical College, go to: https://news.weill.cornell.edu/news/2013/05/cocaine-vaccine-passes-key-testing-hurdle.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.